Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OptiBiotix HealthSTU:OB3 14-Day RSI is 27.90 as of Jul. 25, 2026. The stock has 4 warning signs investors should review. Among 1,424 Biotechnology companies, OptiBiotix Health ranks better than 96.91% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The industry rank for OptiBiotix Health's 14-Day RSI or its related term are showing as below:
STU:OB3's 14-Day RSI is ranked better than 96.91% of 1424
companies
in the Biotechnology industry
Industry Median: 45.5
vs STU:OB3: 27.90
OptiBiotix Health (STU:OB3) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
OptiBiotix Health 14-Day RSI Related Terms
STU:OB3 vs VRTX, REGN, ALNY: 14-Day RSI Comparison
For the Biotechnology subindustry, OptiBiotix Health's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OptiBiotix Health 14-Day RSI vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OptiBiotix Health's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where OptiBiotix Health's 14-Day RSI falls into.
OptiBiotix Health (STU:OB3) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OptiBiotix Health (STU:OB3) has a 14-Day RSI of 27.90 as of Jul. 25, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on OptiBiotix Health and its competitors. According to the industry distribution chart, OptiBiotix Health ranks #44 out of 1424 companies in the Biotechnology industry, placing it in the top 3.1%.
Is OptiBiotix Health's 14-Day RSI too high?
OptiBiotix Health's current 14-Day RSI is 27.90. The Biotechnology industry median 14-Day RSI is 45.50. OptiBiotix Health's value of 27.90 is 38.7% below this industry median. Based on the distribution chart, OptiBiotix Health ranks #44 out of 1424 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does OptiBiotix Health's 14-Day RSI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, OptiBiotix Health ranks #44 out of 1424 companies for 14-Day RSI. This places OptiBiotix Health in the top 3% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 45.50. OptiBiotix Health's value of 27.90 is 38.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Biotechnology company?
The median 14-Day RSI among Biotechnology companies is 45.50, based on 1,424 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OptiBiotix Health's current 14-Day RSI of 27.90 is 38.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on OptiBiotix Health and its competitors. For the Biotechnology industry, the median 14-Day RSI is 45.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OptiBiotix Health's current 14-Day RSI is 27.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OptiBiotix Health stock overvalued right now?
OptiBiotix Health (STU:OB3) has a current 14-Day RSI of 27.90. The stock's GF Value™ is €0.34, compared to a current price of €0.06 — trading 81.6% below its estimated fair value. The current 14-Day RSI is 27.90 and 38.7% below the Biotechnology industry median of 45.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For OptiBiotix Health (STU:OB3), the current 14-Day RSI is 27.90 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. It is a life sciences business focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. Its product portfolio includes First-generation products- SlimBiome, WellBiome; and Second-generation solutions- SweetBiotix, Microbiome Modulators. The group has one class of business. It has presence in United Kingdom, United States, India China, and Rest of world. The company generates majority of revenue from United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OB3 has been successfully added to your 
